| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V128025 | ABBV-011 | ABBV-011 is an antibody-drug conjugate (ADC) that targets SEZ6. | |
|
V97196 | ADC Control Human IgG1-Deruxtecan (DAR 8) | ADC Control Human IgG1-Deruxtecan (DAR 8) is a humanized monoclonal antibody that serves as an isotype control for the ADC Human IgG1-Deruxtecan, which inhibits DNA topoisomerase I. | |
|
V128294 | ADC Control Human IgG1-DL-01 | ADC Control Human IgG1-DL-01 is an antibody-drug conjugate (ADC) consisting of the ADC antibody Human IgG1 lambda1, an isotype control, and the linker payload DL-01 formic acid. | |
|
V103649 | ADC Control human IgG1-DM1 | ADC Control Human IgG1-DM1 is an ADC control consisting of human IgG1 kappa, isotype control, and linker-drug conjugate SMCC-DM1. | |
|
V103949 | ADC Control Human IgG1-DM4 | ADC Control Human IgG1-DM4 is the isotype control of ADC Human IgG1-DM4. The antibody part is Human IgG1 kappa, isotype control, and the ADC virulence molecule and linker part are SPDB-DM4. | |
|
V128295 | ADC Control Human IgG1-ED04 | ADC Control Human IgG1-ED04 is an ADC control consisting of human IgG1 kappa, isotype control, and ADC toxin ED04. | |
|
V104022 | ADC Control Human IgG1-McMMAF | ADC Control Human IgG1-McMMAF is an antibody-drug conjugate (ADC) composed of the ADC antibody IgG1 human IgG1 kappa, isotype control, and payload McMMAF. | |
|
V103948 | ADC Control Human IgG1-SN-38 | ADC Control Human IgG1-SN-38 is an isotype control for ADC Human IgG1-SN-38. | |
|
V116955 | ADC Control Human IgG1-sulfo-SPDB-DM4 | ADC Control Human IgG1-sulfo-SPDB-DM4 is an antibody-drug conjugate (ADC) that inhibits microtubule polymerization. | |
|
V117122 | ADC Control Human IgG1-tirumotecan | ADC reference standard human IgG1-tirumotecan is an antibody-drug conjugate (ADC). | |
|
V128296 | ADC Control Human IgG1-vcMMAE (solution) | ADC Control Human IgG1-vcMMAE (solution) is a humanized monoclonal antibody that serves as an isotype control of ADC human IgG1-vcMMAE and inhibits microtubule polymerization. | |
|
V128831 | Anetumab ravtansine | 1375258-01-7 | Anetumab ravtansine is a highly selective and active antibody-drug conjugate (ADC) that targets maytansin-like microtubules. |
|
V94359 | Anti-CD22-NMS249 | Anti-CD22-NMS249 is a CD22-targeting antibody-drug conjugate (ADC) composed of the humanized anti-CD22 antibody Pinatuzumab, a cleavable linker (Mc-VC-PAB), and a DNA topoisomerase II inhibitor. | |
|
V129581 | Atezolizumab-MMAE | Atezolizumab-MMAE is an anti-PD-L1 antibody-drug conjugate (ADC) with an EC50 of 1.1 nM. | |
|
V129811 | Azintuxizumab vedotin | 1826819-58-2 | Azintuxizumab vedotin is an antibody-drug conjugate (ADC) that targets a unique epitope of CD2 subset 1, a cell surface glycoprotein expressed on multiple myeloma cells. |
|
V119061 | BB-1701 | BB-1701 is an anti-HER2 antibody-drug conjugate (ADC). | |
|
V129979 | Becotatug vedotin | Becotatug vedotin is an antibody-drug conjugate (ADC) composed of the anti-EGFR humanized IgG1 monoclonal antibody Becotatug and MMAE. | |
|
V104014 | Calotatug ginistinag | 2847102-44-5 | Calotatug ginistinag (XMT-2056) is a HER2-targeting antibody-drug conjugate linked to a payload consisting of a linker (XMT-1519 conjugate-1) and a STING agonist (STING agonist-20) with potential immune-activating and anti-tumor activities. |
|
V118385 | DS-3939a | DS-3939a (DS-3939) is an antibody-drug conjugate (ADC) targeting TA-MUC1. | |
|
V117291 | Emiltatug ledadotin | 2855974-40-0 | Emiltatug ledadotin (Emi-Le; XMT-1660) is an antibody-drug conjugate (ADC) that targets B7-H4. |